Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO)
THOUSAND OAKS, Calif. and LONDON, July 27 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN ) and GlaxoSmithKline (GSK) today announced a collaboration in which the companies will share commercialization of Amgen's monoclonal antibody denosumab for postmenopausal osteoporosi...
Amylin Pharmaceuticals to Present at Piper Jaffray Europe Conference
SAN DIEGO, June 17 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) will be presenting at the Piper Jaffray Europe
Conference in London on Wednesday, June 24, 2009 at 10:30 a.m. British Summer Time/ 5:30 a.m. ET. Daniel M. Bradbury, president and chief executive officer o...
New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives
Three-of-Four Patients Surveyed Experience Daily Pain From Rheumatoid Arthritis Despite Current Treatment; Findings Unveiled at the European League Against Rheumatism Annual Congress of Rheumatology
COPENHAGEN, Denmark, June 10 /PRNewswire-FirstCall/ -- Results from the Rheumatoid Arthritis: ...
OmniComm Systems Appoints EDC Veteran Dr. Wolfgang Summa to Executive Vice President, Europe & Asia/Pacific
OMNICOMM CONTINUES ITS EXPANSION INTO EUROPE
AND STRENGTHENS ITS SENIOR MANAGEMENT TEAM
FT. LAUDERDALE, Fla., May 12 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions for clinical trials, today anno...
ZyGEM Corp. and VWR International Europe BVBA Sign Agreement to Distribute Breakthrough DNA Extraction Technology in Europe
- Extends Successful Existing Distribution Agreement for the Americas -
- The Agreement for Europe
Will Ensure Researchers Can Easily Access ZyGEM's Growing Line of DNA Extraction Kits -
- ZyGEM's Technology Enables Lower-Cost DNA Extraction and Is Ideally Suited to Automation and High-T...
Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site
PRINCETON, N.J., March 13 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD ) announced today that it is expanding its clinical pharmacology footprint in Europe
with the acquisition of Swiss Pharma Contract, a 50-bed clinical research company based in Basel, Switzerland.
"Our clients' need ...
Campbell Alliance Brand Management Practice to Present at EyeForPharma's Oncology Summit USA and Oncology Market Access Europe Conference
RALEIGH, N.C., March 10 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that Ashwin Dandekar, Vice President, Brand Management Practice, will present a session at EyeforPharma's Oncology Summit USA...
Physicians in Europe Rate Novartis #1 on Service Delivery, While Merck Earns Top Honors in the US
Even Among Companies Doing Well, Relationships Weaken in Many Countries
NEW YORK, Feb. 17 /PRNewswire/ -- New TNS Healthcare research shows that physicians in four out of the five major European countries -- the UK, Germany, Spain and Italy -- give Novartis top marks for effectively deliverin...
New Biologic STELARA(TM) Receives Approval in Europe for Treatment of Moderate to Severe Plaque Psoriasis
First and Only Biologic Approved with Infrequent, Every Twelve-Week Maintenance Dosing
BEERSE, Belgium, Jan. 22 /PRNewswire/ -- Janssen-Cilag announced today that STELARA(TM) (ustekinumab), the first in a new class of biologics, has been approved by the European Commission for use across Eu...
Seasonal Influenza Activity Increasing Across Europe - H3N2 Dominant Strain
BASEL, Switzerland, January 19 /PRNewswire-FirstCall/ --
- Tamiflu Remains Fully Effective Against 94 Percent of Circulating
Influenza Viruses in Europe
Latest surveillance data coming through the European Centre for Disease
Prevention and Control (ECDC) from virologists and clin...
Epeius Biotech Awarded Patents in Europe for Targeted Genetic Anti-Cancer Medicine: Company Expands Impressive Intellectual Property Estate
SAN MARINO, Calif., Dec. 16 /PRNewswire/ -- Epeius Biotechnologies
Corporation, a leader in tumor-targeted gene delivery systems, has received
two additional European patents for the platform targeting technologies and
molecular designs that enable precision gene delivery to primary cancers and
CeloNova BioSciences Commercializes CATANIA(TM) Coronary Stent With NanoThin Polyzene(R)-F in Europe and Middle East
NEWNAN, Ga., Dec. 3 /PRNewswire/ -- CeloNova BioSciences, Inc., announced
today that it has expanded the areas in which it is commercializing the
CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F -- a stent
system that has not had any stent thrombosis in clinical studies. It is CE
EntreMed to Present at BioPartnering Europe Conference
ROCKVILLE, Md., Oct. 10 /PRNewswire-FirstCall/ -- EntreMed, Inc.
(Nasdaq: ENMD ) a clinical-stage pharmaceutical company developing
therapeutics for the treatment of cancer and inflammatory diseases,
announced today that Thomas H. Bliss, Jr., EntreMed's Senior Vice
President, Corporate and Bu...
Totoku Europe Chooses Matrox Xenia(TM) Series to Drive Medical Monitors
MONTREAL, Oct. 8 /PRNewswire/ -- Matrox Graphics Inc., the leading
manufacturer of specialized graphics solutions, confirms that Totoku Europe
will be shipping Matrox Xenia(TM) Series display controller boards with its
ME/CCL medical LCD displays.
Matrox Xenia is the first native PCI Express...
BioMS Medical to present at Sachs Associates Biotech in Europe Forum
Toronto Stock Exchange Symbol: MS
EDMONTON, Sept. 19 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX:
MS), a leading developer in the treatment of multiple sclerosis (MS), today
announced that Mr. Tony Hesby, Executive Vice President, Corporate Affairs,
will present at the Sachs Associates ...
Quark Pharmaceuticals Announces Poster Presentations at RNAi Europe 2008
FREMONT, Calif., Sept. 17 /PRNewswire/ -- Quark Pharmaceuticals, Inc.,
a development-stage pharmaceutical company discovering and developing novel
RNA interference (RNAi)-based therapeutics, today announced the
presentation of posters at the 5th Annual RNAi Europe, taking place
CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
- Upfront, milestone payments and promotional investment totaling up to $385 million plus royalties -
PALO ALTO, Calif., Sept. 12 /PRNewswire-FirstCall/ -- CV Therapeutics,
Inc. (Nasdaq: CVTX ) announced today that it has entered into an agreement
granting exclusive rights...
Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification
SAN DIEGO, July 14 /PRNewswire-FirstCall/ -- Cardium Therapeutics
(Amex: CXM ) and its operating unit InnerCool Therapies, Inc., announced
today that InnerCool's RapidBlue(TM) endovascular temperature modulation
system conforms to the European Union CE Mark requirements for use in
Medicsight to Present at Piper Jaffray Annual Europe Conference
NEW YORK, June 23 /PRNewswire-FirstCall/ -- Medicsight PLC, a
subsidiary of MGT Capital Investments, Inc. (Amex: MGT ), and an industry
leader in the development of Computer-Aided Detection (CAD) and image
analysis software, today announces that Allan Rowley (CFO) and Lucan Toh
(Director of B...
deCODE genetics to Webcast Presentation at Piper Jaffray Europe Conference
REYKJAVIK, Iceland, June 19 /PRNewswire-FirstCall/ -- deCODE genetics
(Nasdaq: DCGN ) today announced that it will host a live webcast of deCODE
CEO Kari Stefansson's presentation at the Piper Jaffray Europe
The presentation will be delivered on Wednesday, June 25, at 7am
Exelixis Announces June 25 Webcast of Presentation at the Piper Jaffray Europe Conference
SOUTH SAN FRANCISCO, Calif., June 18 /PRNewswire-FirstCall/ --
Exelixis, Inc. (Nasdaq: EXEL ) announced today that Frank Karbe, executive
vice president and chief financial officer at Exelixis, will present at the
Piper Jaffray Europe
Conference at 3:40 a.m. PT/6:40 a.m. ET/11:40 a.m.
Novavax CEO to Present at Piper Jaffray Europe Conference, London, UK
ROCKVILLE, Md., June 16 /PRNewswire-FirstCall/ -- Novavax, Inc.
(Nasdaq: NVAX ) a clinical-stage vaccine company, announced today that Dr.
Rahul Singhvi, President and Chief Executive Officer, will be presenting at
the Piper Jaffray Europe
conference at 11:20 am. (GMT) on June 24, 2008 at
Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
SAN DIEGO, May 28 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated
(Nasdaq: GPRO ) announced today that the Company has launched in Europe
APTIMA(R) HPV Assay, a highly specific molecular diagnostic test to detect
high-risk strains of the human papillomavirus (HPV), which causes cervical
Top Cancer Hospitals in Denmark and Netherlands First in Europe to Treat Patients With RapidArc(TM) Radiotherapy
New technology from Varian Medical Systems delivers faster image-guided
intensity-modulated radiotherapy (IMRT) to target tumors while sparing more healthy tissue
COPENHAGEN, Denmark and AMSTERDAM, Netherlands, May 14
/PRNewswire-FirstCall/ -- Doctors in Denmark and...
Campbell Alliance Sales Practice to Conduct Workshop at EyeForPharma SFE Europe Conference
RALEIGH, N.C., March 26 /PRNewswire/ -- Campbell Alliance, the leading
management consulting firm specializing in the pharmaceutical and
biotechnology industry, announced today that George Schmidt, Vice President
in the firm's Sales Practice, will present a workshop at the EyeForPharma
Medarex Receives Milestone Payment for Submission of Regulatory Application Requesting Approval of Golimumab (CNTO 148) in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
PRINCETON, N.J., March 20 /PRNewswire-FirstCall/ -- Medarex, Inc.
(Nasdaq: MEDX ) today announced that it has received a milestone payment of
an undisclosed amount from its licensing partner, Centocor, Inc., for the
submission of a Marketing Authorization Application to the European
Centocor, Inc. and Schering-Plough Submit Application Requesting Approval of Golimumab in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
HORSHAM, Pa. and KENILWORTH, N.J., March 18 /PRNewswire/ -- Centocor,
Inc. and Schering-Plough Corporation (NYSE: SGP ) announced today that a
Marketing Authorization Application (MAA) has been submitted to the
European Medicines Agency (EMEA) requesting the approval of golimumab (CNTO
Vaccinogen's New Anti-Cancer Vaccine Commercially Available in Europe This Year
FREDERICK, Md., Feb. 27 /PRNewswire/ -- Vaccinogen, Inc. announced that
its new vaccine to block colon cancer from recurring will be commercially
available in Europe
starting June 2008.
"This makes OncoVAX(R) the world's first commercially viable vaccine
for colon cancer," said Dr. Michael G...
Sensitech to Sponsor Panel Session at IQPC Cool Chain Europe 2008
SASSENHEIM, Netherlands, Jan. 9 /PRNewswire/ -- Sensitech, the global
leader in cold chain visibility solutions, will sponsor "Cool Chain
Integrity and Visibility - A Discussion and Review of Industry
Implementation Trends and Expectations for Return on Investment" at IQPC
Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer
Avastin offers patients the chance to live twice as long without their disease advancing
BASEL, Switzerland, Dec. 19 /PRNewswire/ -- Avastin (bevacizumab),
Roche's innovative anti-cancer drug, was approved today in Europe
first-line treatment of patients with...
Vaccinex, Inc. Announces Award of Key Patent in Europe for its Antibody Discovery Technology (ActivMab(R))
ROCHESTER, N.Y., Nov. 30 /PRNewswire/ -- Vaccinex, Inc. announced today
the award of a key European patent (European Patent No. 1340088) for its
antibody discovery technology platform, branded as ActivMab(R) Technology.
Vaccinex is using its patented technology to discover and develop new
DAIICHI SANKYO EUROPE is Applying for Approval of its New Combination Product of Olmesartan and Amlodipin
MUNICH, Germany, October 1 /PRNewswire/ -- - New Product Under Development for the Treatment of High Blood
Pressure - Approval Requested in 28 European Countries DAIICHI SANKYO EUROPE
GmbH has applied in 28 European countries for
approval of a new antihypertensive medication. It is a fixed ...
Micromet to Present at the Sachs Associates 7th Annual Biotech in Europe Investor Forum
BETHESDA, Md., Sept. 26 /PRNewswire-FirstCall/ -- Micromet, Inc.
(Nasdaq: MITI ), a biopharmaceutical company focusing on the development of
novel, proprietary antibody-based products for cancer, inflammation and
autoimmune diseases, today announced that Dr. Christian Itin, President and
ThalesNano Inc. Opens Own Representation in the United Kingdom and has New Distribution Agreements for Europe and India
BUDAPEST, Hungary, September 24 /PRNewswire/ -- ThalesNano Inc., a
leading developer and manufacturer of flow chemistry, flow reactor
technology, and hydrogenation technology solutions, announced today that it
had continued to expand globally by opening a subsidiary in the United
Kingdom and b...
Luminex Corporation Hosts the Fifth Annual Planet xMAP Europe 2007 Symposium
Two-Day Multiplexing Technology Symposium Brings Together Thought Leaders
in Life Sciences and Clinical Diagnostics to Share Ideas and Best Practices
OOSTERHOUT, Netherlands, Sept. 13 /PRNewswire-FirstCall/ -- Luminex
Corporation (Nasdaq: LMNX ), the world leader in multiplexed solutions,
Robust Annual Growth Through 2012 in the Age-Related Macular Degeneration Market Will Be Driven by Expanding Use of Lucentis in Europe
However, Off-Label Use of Avastin Will Take Market Share Away from Lucentis from 2012 to 2017, According to a New Report from Decision Resources
WALTHAM, Mass., March 10 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcar...
Tolerx Expands Phase 3 'DEFEND' Trial of Otelixizumab in Europe
CAMBRIDGE, Mass., March 10 /PRNewswire/ -- Tolerx, Inc., today announced that DEFEND ( D urable Response Therapy E valuation F or E arly or N ew Onset Type 1 D iabetes), the Phase 3 trial of otelixizumab, an investigational novel targeted immunotherapeutic, has begun enrollment of new onset a...
Valdoxan(R) Granted Marketing Authorisation for the Treatment of Major Depressive Episodes in Europe
PARIS, January 24 /PRNewswire/ -- The European Commission has granted
marketing authorisation for Servier's Valdoxan(R) /Thymanax(R) (agomelatine),
the first melatonergic antidepressant for the treatment of adult patients
with major depressive episodes.
"There is still great scope for i...
Elsevier Introduces Breakthrough Technology Intelligence Solution for Accelerating R&D and Innovation in Europe
AMSTERDAM, January 22 /PRNewswire-FirstCall/ --
- illumin8 Combines Scientific Content From Elsevier and Other
Publishers, Web and Patent Content With Intelligent Web Search Technology to
Address Complex Technology and Market Landscape Questions Faster and More
Life Science Alley: R&D Makes German Medical Technologies Top in Europe
BERLIN, December 8 /PRNewswire/ -- Germany is Europe's largest market for
medical devices. Total industry revenue in 2007 amounted to EUR 17.3 billion
- a nearly 7 percent increase on 2006 figures. Investors looking to enter the
German and European markets can learn about Germany at Life Science A...